Researchers have shown that ultrasound can enhance the ability of tumor cells in pancreatic patients to absorb chemotherapeutics, can nearly double the median survival time from diagnosis, and can cause recession of tumors. The researchers in Norway combined ‘sonoporation’, an ultrasound technique, with the Gemcitabine chemotherapy. Sonoporation increases the porosity of pancreatic cells using microbubbles, … Continue reading Clinical Trial Suggests Sonoporation Could Double Survival Time for Pancreatic Cancer Patients